SNY vs. EDIT
SNY (Sanofi) and EDIT (Editas Medicine, Inc.) are both stocks. Both are in the Healthcare sector — SNY in Drug Manufacturers - General, EDIT in Biotechnology. Over the past 10 years, SNY returned 5.78%/yr vs -22.22%/yr for EDIT. At a 0.20 correlation, their price movements are largely independent.
Performance
SNY vs. EDIT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SNY achieves a -3.62% return, which is significantly lower than EDIT's 21.95% return. Over the past 10 years, SNY has outperformed EDIT with an annualized return of 5.78%, while EDIT has yielded a comparatively lower -22.22% annualized return.
SNY
- 1D
- 0.32%
- 1M
- 3.65%
- YTD
- -3.62%
- 6M
- -4.06%
- 1Y
- -5.97%
- 3Y*
- 0.21%
- 5Y*
- 0.40%
- 10Y*
- 5.78%
EDIT
- 1D
- 2.46%
- 1M
- -4.58%
- YTD
- 21.95%
- 6M
- -1.19%
- 1Y
- 26.90%
- 3Y*
- -39.82%
- 5Y*
- -41.79%
- 10Y*
- -22.22%
SNY vs. EDIT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SNY Sanofi | -3.62% | 4.93% | 1.09% | 6.55% | 0.57% | 7.00% | 0.39% | 20.47% | 6.06% | 9.96% |
EDIT Editas Medicine, Inc. | 21.95% | 61.42% | -87.46% | 14.21% | -66.59% | -62.13% | 136.78% | 30.15% | -25.97% | 89.34% |
Correlation
The correlation between SNY and EDIT is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Feb 3, 2016 | 0.20 |
Fundamentals
SNY:
$106.57B
EDIT:
$244.70M
SNY:
€3.09
EDIT:
-$1.21
SNY:
1.98
EDIT:
6.29
SNY:
1.27
EDIT:
55.51
SNY:
€47.35B
EDIT:
$35.86M
SNY:
€34.18B
EDIT:
$35.86M
SNY:
€12.63B
EDIT:
-$76.66M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SNY vs. EDIT — Risk / Return Rank
SNY
EDIT
SNY vs. EDIT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Editas Medicine, Inc. (EDIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SNY | EDIT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.47 | ||
| Sortino ratioReturn per unit of downside risk | -1.25 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.11 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | -0.49 | 0.25 | -0.73 |
| Martin ratioReturn relative to average drawdown | -0.96 | 0.43 | -1.39 |
Loading charts...
Drawdowns
SNY vs. EDIT - Drawdown Comparison
The maximum SNY drawdown since its inception was -46.46%, smaller than the maximum EDIT drawdown of -98.92%. Use the drawdown chart below to compare losses from any high point for SNY and EDIT.
Loading charts...
Drawdown Indicators
| SNY | EDIT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -46.46% | -98.92% | +52.46% |
Max Drawdown (1Y)Largest decline over 1 year | -16.70% | -59.88% | +43.18% |
Max Drawdown (3Y)Largest decline over 3 years | -23.37% | -91.18% | +67.81% |
Max Drawdown (5Y)Largest decline over 5 years | -33.52% | -98.66% | +65.14% |
Max Drawdown (10Y)Largest decline over 10 years | -33.52% | -98.92% | +65.40% |
Current DrawdownCurrent decline from peak | -17.91% | -97.24% | +79.33% |
Average DrawdownAverage peak-to-trough decline | -12.20% | -62.63% | +50.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.63% | 34.03% | -25.40% |
Volatility
SNY vs. EDIT - Volatility Comparison
The current volatility for Sanofi (SNY) is 8.05%, while Editas Medicine, Inc. (EDIT) has a volatility of 32.34%. This indicates that SNY experiences smaller price fluctuations and is considered to be less risky than EDIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SNY | EDIT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.05% | 32.34% | -24.29% |
Volatility (6M)Calculated over the trailing 6-month period | 15.99% | 61.63% | -45.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.71% | 94.75% | -69.04% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.82% | 94.12% | -69.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.47% | 83.80% | -60.33% |
Dividends
SNY vs. EDIT - Dividend Comparison
SNY's dividend yield for the trailing twelve months is around 5.47%, while EDIT has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EDIT Editas Medicine, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SNY Sanofi | 5.47% | 4.56% | 4.22% | 3.83% | 4.32% | 3.80% | 3.61% | 3.47% | 4.29% | 3.82% | 4.11% | 3.77% |
Financials
SNY vs. EDIT - Financials Comparison
This section allows you to compare key financial metrics between Sanofi and Editas Medicine, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SNY and EDIT have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EDIT has higher volatility (32.34%) compared to SNY (8.05%). In terms of maximum drawdown, SNY dropped -46.46% vs EDIT's -98.92%.
EDIT currently has the higher Sharpe Ratio (0.16 vs -0.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SNY and EDIT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer